Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of diabetes worldwide
3.2.1.2 Technological advancements
3.2.1.3 Rising demand for self-monitoring devices globally
3.2.1.4 Government initiatives for increasing awareness among people
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced devices and accessories
3.2.2.2 Lack of reimbursement and stringent regulations
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Porter's analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Self-monitoring blood glucose meters
5.3 Continuous glucose monitors
5.3.1 Wearable
5.3.2 Non - wearable
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Type 1 diabetes
6.3 Type 2 diabetes
6.4 Gestational diabetes
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacies
7.3 Retail pharmacies
7.4 Online sales
7.5 Diabetes clinics & centers
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 Sweden
8.3.9 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.5.7 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Kuwait
8.6.4 UAE
8.6.5 Turkey
8.6.6 Egypt
8.6.7 Israel
8.6.8 Qatar
8.6.9 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AgaMatrix
9.3 All Medicus Co., Ltd.
9.4 Ascensia Diabetes Care Holdings AG
9.5 Arkray, Inc.
9.6 B. Braun Melsungen AG
9.7 Bionime Corporation
9.8 DarioHealth Corporation
9.9 Dexcom, Inc.
9.10 Essenlife Bioscience, Inc.
9.11 F. Hoffmann-La Roche Ltd.
9.12 LifeScan Inc.
9.13 Medtronic plc
9.14 Nova Biomedical, Inc.
9.15 Sinocare Inc.
